hotspot -WSS

hotspot

author：explore 2025-10-02 13:14:19 - browse：2

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Why Novartis is changing the name of its research labs

focus

WSS

What drug price negotiations mean for Medicare Part D

IVF doctors demand details after CooperSurgical lawsuit

Crinetics acromegaly drug succeeds in late

How to fix cancer clinical trials' diversity problem

IVF doctors demand details after CooperSurgical lawsuit

Crinetics acromegaly drug succeeds in late

knowledge

hotspot

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

Stem cell treatment guidelines are released by FDA

Malaria cases in Florida and Texas: Here’s what you need to know

Listen: Biogen's potential pivot, & Illumina's next chapter

The high cost of giving birth even with insurance

Ethical issues complicate the benefits of medical crowdfunding

The high cost of giving birth even with insurance

Trump surgeon general acknowledges mistakes during Covid

Medicare details structure of new drug price negotiation program

'Make People Better': The CRISPR babies story you probably don't know

knowledge

Medicaid rebukes states for mistakenly disenrolling children

Medicare drug price negotiation hearing pits pharma v Biden admin

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

For AI in health care standards, federal regulators join with industry group

Pregnant women don't need prenatal multivitamins, study concludes

NIH nominee Bertagnolli will get October confirmation hearing

focus

explore

knowledge

focus